drugset / Trial / NCT03668665

Influencing Wound Healing Through the Application of Hyaluronic Acid With Perfluorodecalin and Physalis Angulata Extract After Split Skin Removal From the Thigh - A Study in "Split Wound Design"

NCT03668665 ↗

Phase 3 Withdrawn RWTH Aachen University
RandomizedParallel-groupTriple-blindTreatment

Summary

The study will use a split wound design to investigate whether secondary wound healing can be accelerated and improved by the application of hyaluronic acid combined with perfluorodecalin and Physalis angulata extract.

Timeline

Start
2018-10
Primary completion
2020-04
Completion
2020-10

Outcome

Outcome not reported

Stopped: “no approval by CA”

Drugs

EvaluationDrugModalityDoseRoute
Subject Ready Medical Post Treatment Unknown — —

Indications

No indication recorded.